Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Preclinical studies indicate potential for ISAtx-247 in diabetes treatment

Oct. 5, 2000

Mevinolin derivatives for disorders mediated by LFA-1/ICAM-1 interactions

Oct. 3, 2000

Milestone reached in MorphoSys and GPC Biotech immunology therapeutics program

Sep. 28, 2000

SangStat's Thymoglobulin granted orphan drug designation in U.S.

Sep. 26, 2000

Baxter and Peptide Therapeutics enter collaboration for vaccine development

Sep. 22, 2000

Pseudo-proline-containing ciclosporin derivatives useful as prodrugs

Sep. 19, 2000

HuM291 appears to induce transplant tolerance via apoptosis of activated T-cells

Sep. 14, 2000

DNA vaccine encoding C3d enhances immune response to influenza

Sep. 13, 2000

SDZ-RAD continues to shine as a potential agent for transplantation

Sep. 13, 2000

Immunosuppressive effects of new peptide confirmed; additional hypolipidemic effects seen

Sep. 12, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...